SEARCH

SEARCH BY CITATION

References

  • Anand, G.S., Law, D., Mandell, J.G., Snead, A.N., Tsigelny, I., Taylor, S.S., Eyck, L.F.T., and Komives, E.A. 2003. Identification of the protein kinase A regulatory RIα-catalytic subunit interface by amide H/2H exchange and protein docking. Proc. Natl. Acad. Sci. 100: 1326413269.
  • Bai, Y., Milne, J.S., Mayne, L., and Englander, S.W. 1993. Primary structure effects on peptide group hydrogen exchange. Proteins 17: 7586.
  • Bajaj, S.P., Schmidt, A.E., Agah, S., Bajaj, M.S., and Padmanabhan, K. 2006. High resolution structures of p-aminobenzamidine- and benzamidine-VIIa/soluble tissue factor: Unpredicted conformation of the 192–193 peptide bond and mapping of Ca2+, Mg2+, Na+ and Zn2+ sites in factor VIIa. J. Biol. Chem. 281: 2487324888.
  • Banner, D.W., D'Arcy, A., Chène, C., Winkler, F.K., Guha, A., Konigsberg, W.H., Nemerson, Y., and Kirchhofer, D. 1996. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 380: 4146.
  • Davie, E.W., Fujikawa, K., and Kisiel, W. 1991. The coagulation cascade: Initiation, maintenance, and regulation. Biochemistry 30: 1036310370.
  • Dickinson, C.D., Kelly, C.R., and Ruf, W. 1996. Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease factor VIIa. Proc. Natl. Acad. Sci. 93: 1437914384.
  • Dickinson, C.D. and Ruf, W. 1997. Active site modification of factor VIIa affects interactions of the protease domain with tissue factor. J. Biol. Chem. 272: 1987519879.
  • Eigenbrot, C., Kirchhofer, D., Dennis, M.S., Santell, L., Lazarus, R.A., Stamos, J., and Ultsch, M.H. 2001. The factor VII zymogen structure reveals reregistration of β strands during activation. Structure 9: 627636.
  • Englander, S.W., Sosnick, T.R., Englander, J.J., and Mayne, L. 1996. Mechanisms and uses of hydrogen exchange. Curr. Opin. Struct. Biol. 6: 1823.
  • Essman, U., Perera, L., Berkowitz, T., Darden, T., Lee, H., and Pedersen, L.G. 1995. A smooth particle mesh method. J. Chem. Phys. 103: 85778593.
  • Fehlhammer, H., Bode, W., and Huber, R. 1977. Crystal-structure of bovine trypsinogen at 1.8 Å resolution: Crystallographic refinement, refined crystal-structure and comparison with bovine trypsin. J. Mol. Biol. 111: 415438.
  • Feller, S.E., Zhang, Y., Pastor, R.W., and Brooks, B.R. 1995. Constant pressure molecular dynamics simulation: The Langevin piston method. J. Chem. Phys. 103: 46134621.
  • Freskgård, P.O., Olsen, O.H., and Persson, E. 1996. Structural changes in factor VIIa induced by Ca2+ and tissue factor studied using circular dichroism spectroscopy. Protein Sci. 5: 15311540.
  • Gullingsrud, J. and Schulten, K. 2003. Gating of MscL studied by steered molecular dynamics. Biophys. J. 85: 20872099.
  • Higashi, S., Nishimura, H., Aita, K., and Iwanaga, S. 1994. Identification of regions of bovine factor VII essential for binding to tissue factor. J. Biol. Chem. 269: 1889118898.
  • Hoofnagle, A.N., Resing, K.A., and Ahn, N.G. 2003. Protein analysis by hydrogen exchange mass spectrometry. Annu. Rev. Biophys. Biomol. Struct. 32: 125.
  • Huber, R. and Bode, W. 1978. Structural basis of activation and action of trypsin. Acc. Chem. Res. 11: 114122.
  • Hvidt, Å. and Nielsen, S.O. 1966. Hydrogen exchange in proteins. Adv. Protein Chem. 21: 287386.
  • Isralewitz, B., Gao, M., and Schulten, K. 2001. Steered molecular dynamics and mechanical functions of proteins. Curr. Opin. Struct. Biol. 11: 224230.
  • Jensen, M.O., Tajkhorshid, E., and Schulten, K. 2001. The mechanism of glycerol conduction in aquaglyceroporins. Structure 9: 10831093.
  • Jensen, M.O., Park, S., Tajkhorshid, E., and Schulten, K. 2002. Energetics of glycerol conduction through aquaglyceroporin GlpF. Proc. Natl. Acad. Sci. 99: 67316736.
  • Johnson, D.J.D., Adams, T.E., Li, W., and Huntington, J.A. 2005. Crystal structure of wild-type human thrombin in the Na+-free state. Biochem. J. 392: 2128.
  • Kabsch, W. and Sander, C. 1983. Dictionary of protein secondary structure: Pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22: 25772637.
  • Karplus, M. and Kuriyan, J. 2005. Chemical theory and computation special feature: Molecular dynamics and protein function. Proc. Natl. Acad. Sci. 102: 66796685.
  • Kemball-Cook, G., Johnson, D.J.D., Tuddenham, E.G.D., and Harlos, K. 1999. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla). J. Struct. Biol. 127: 213223.
  • Mandell, J.G., Falick, A.M., and Komives, E.A. 1998. Identification of protein–protein interfaces by decreased amide proton solvent accessibility. Proc. Natl. Acad. Sci. 95: 1470514710.
  • Martyna, G.J., Tobias, D.J., and Klein, M.L. 1994. Constant pressure molecular dynamics algorithms. J. Chem. Phys. 101: 41774189.
  • McKerell, A.D. Jr, Bashford, D., Bellott, M., Dunbrack, R.L. Jr, Evanseck, J., Field, M.J., Fisher, S., Gao, J., Guo, H., Ha, S., et al. 1998. All-hydrogen empirical potential for molecular modelling and dynamics studies of proteins using the CHARMM22 force field. J. Phys. Chem. 102: 35863616.
  • Olsen, O.H., Nielsen, P.F., and Persson, E. 2004. Prevention of β strand movement into a zymogen-like position does not confer higher activity to coagulation factor VIIa. Biochemistry 43: 1409614103.
  • Perera, L. and Pedersen, L.G. 2005. A reconsideration of the evidence for structural reorganization in FVII zymogen. J. Thromb. Haemost. 3: 15431545.
  • Persson, E. 1997. Characterization of the interaction between the light chain of factor VIIa and tissue factor. FEBS Lett. 413: 359363.
  • Persson, E., Bak, H., and Olsen, O.H. 2001a. Substitution of valine for leucine 305 in factor VIIa increases the intrinsic enzymatic activity. J. Biol. Chem. 276: 2919529199.
  • Persson, E., Kjalke, M., and Olsen, O.H. 2001b. Rational design of coagulation factor VIIa variants with substantially increased intrinsic activity. Proc. Natl. Acad. Sci. 98: 1358313588.
  • Persson, E., Nielsen, L.S., and Olsen, O.H. 2001c. Substitution of aspartic acid for methionine-306 in factor VIIa abolishes the allosteric linkage between the active site and the binding interface with tissue factor. Biochemistry 40: 32513256.
  • Persson, E., Bak, H., Østergaard, A., and Olsen, O.H. 2004. Augmented intrinsic activity of Factor VIIa by replacement of residues 305, 314, 337 and 374: Evidence of two unique mutational mechanisms of activity enhancement. Biochem. J. 379: 497503.
  • Petrovan, R.J. and Ruf, W. 2000. Role of residue Phe225 in the cofactor-mediated, allosteric regulation of the serine protease coagulation factor VIIa. Biochemistry 39: 1445714463.
  • Petrovan, R.J. and Ruf, W. 2002. Role of zymogenicity-determining residues of coagulation factor VII/VIIa in cofactor interaction and macromolecular substrate recognition. Biochemistry 41: 93029309.
  • Pike, A.C.W., Brzozowski, A.M., Roberts, S.M., Olsen, O.H., and Persson, E. 1999. Structure of human factor VIIa and its implications for the triggering of blood coagulation. Proc. Natl. Acad. Sci. 96: 89258930.
  • Rand, K.D., Jørgensen, T.J.D., Olsen, O.H., Persson, E., Jensen, O.N., Stennicke, H.R., and Andersen, M.D. 2006. Allosteric activation of coagulation factor VIIa visualized by hydrogen exchange. J. Biol. Chem. 281: 2301823024.
  • Ruf, W. and Dickinson, C.D. 1998. Allosteric regulation of the cofactor-dependent serine protease coagulation factor VIIa. Trends Cardiovasc. Med. 8: 350356.
  • Sichler, K., Banner, D.W., D'Arcy, A., Hopfner, K.-P., Huber, R., Bode, W., Kresse, G.-B., Kopetzki, E., and Brandstetter, H. 2002. Crystal structures of uninhibited factor VIIa link its cofactor and substrate-assisted activation to specific interactions. J. Mol. Biol. 322: 591603.
  • Soejima, K., Yuguchi, M., Mizuguchi, J., Tomokiyo, K., Nakashima, T., Nakagaki, T., and Iwanaga, S. 2002. The 99 and 170 loop-modified factor VIIa mutants show enhanced catalytic activity without tissue factor. J. Biol. Chem. 277: 4902749035.
  • Sørensen, B.B., Persson, E., Freskgård, P.O., Kjalke, M., Ezban, M., Williams, T., and Rao, L.V.M. 1997. Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor. J. Biol. Chem. 272: 1186311868.
  • Wales, T.E. and Engen, J.R. 2006. Hydrogen exchange mass spectrometry for the analysis of protein dynamics. Mass Spectrom. Rev. 25: 158170.
  • Zhang, E., St Charles, R., and Tulinsky, A. 1999. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant. J. Mol. Biol. 285: 20892104.